Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$117.8K
20K shares
What this filing means
HALKUFF DAWN plans to sell 20K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $117.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001950047-26-005664
Director
Since Oct 2021
20K
Shares to sell
$117.8K
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/3/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2026 | Restricted Stock Units N/A | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$117.8K
6/4/2026
Total
Units
20K
Value
$117.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/4/2026 | 20K | $117.8K | NASDAQ | Planned |
| Total | 20K | $117.8K | ||